Notification That Annual Report Will Be Submitted Late (nt 10-k)
31 Marzo 2021 - 11:01PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
SEC
FILE NUMBER:
|
000-53223
|
(Check
One):
|
[X]
|
Form
10-K
|
[ ]
|
Form
20-F
|
[ ]
|
Form
11-K
|
[ ]
|
Form
10-Q
|
[ ]
|
Form
N-SAR
|
[ ]
|
Form
N-CSR
|
For
Period Ended: December 31, 2020
|
[ ]
|
Transition
Report on Form 10-K
|
|
[ ]
|
Transition
Report on Form 20-F
|
|
[ ]
|
Transition
Report on Form 11-K
|
|
[ ]
|
Transition
Report on Form 10-Q
|
|
[ ]
|
Transition
Report on Form N-SAR
|
For
the Transition Period Ended:
Nothing
in this form shall be construed to imply that the Commission has
verified
any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Marizyme,
Inc.
Full
Name of Registrant
Former
Name if Applicable
555
Heritage Drive, Suite 205
Address
of Principal Executive Office (Street and Number)
Jupiter,
FL 33458
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
|
|
(a)
|
The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
|
|
|
[X]
|
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion
thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report
or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed
due date; and
|
|
|
|
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III – NARRATIVE
State
below in reasonable detail the reasons why Forms 10-Q, 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report portion thereof,
could not be filed within the prescribed time period.
The
registrant did not obtain all necessary information, the accountants could not complete the required financial statements, and
management could not complete the Management’s Discussion and Analysis of such financial statements prior to the filing
deadline.
PART
IV – OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this notification
|
|
James
Sapirstein
|
|
561
|
|
935-9955
|
|
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed? If answer is no, identify report(s).
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
Marizyme,
Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
March 31, 2021
|
By:
|
/s/
James Sapirstein
|
|
|
James
Sapirstein
InterimChief
Executive Officer
|
Grafico Azioni Marizyme (QB) (USOTC:MRZM)
Storico
Da Ott 2024 a Ott 2024
Grafico Azioni Marizyme (QB) (USOTC:MRZM)
Storico
Da Ott 2023 a Ott 2024